U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. For Health Professionals
  3. Learning Activities
  1. For Health Professionals

Learning Activities

CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health. CDERLearn


Sub-Topic Paragraphs

Latest From the Commissioner

FDA Outlines Steps to Strengthen Tobacco Program

Feb 24

La FDA delinea pasos para fortalecer el Programa Antitabaco

Feb 24

FDA Advances Additional Activities to Prevent Drug Overdoses and Reduce Death

Feb 16

The Federal Response to COVID-19 - 02/08/2023

Feb 08

FDA Proposes Redesign of Human Foods Program to Enhance Coordinated Prevention and Response Activities

Jan 31

FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

Jan 26

La FDA concluye que los marcos regulatorios existentes para alimentos y suplementos no son apropiados para el cannabidiol, trabajará con el Congreso en una nueva forma de proceder

Jan 26

Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

Jan 19

MedWatch Safety Alerts


Stakeholder Update

FDA's Stakeholder Engagement Staff works to provide you with up-to-date information that helps to further our commitment in advancing public health and well-being.

Back to Top